These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36091789)

  • 1. The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria.
    Watson DJ; Laing L; Beteck RM; Gibhard L; Haynes RK; Wiesner L
    Front Pharmacol; 2022; 13():957690. PubMed ID: 36091789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Straightforward conversion of decoquinate into inexpensive tractable new derivatives with significant antimalarial activities.
    Beteck RM; Coertzen D; Smit FJ; Birkholtz LM; Haynes RK; N'Da DD
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3006-3009. PubMed ID: 27210430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoquinate liposomes: highly effective clearance of Plasmodium parasites causing severe malaria.
    Zeng S; Wang H; Tao L; Ning X; Fan Y; Zhao S; Qin L; Chen X
    Malar J; 2022 Jan; 21(1):24. PubMed ID: 35073922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An
    Tanner L; Haynes RK; Wiesner L
    Front Pharmacol; 2019; 10():120. PubMed ID: 30833898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Activity of Decoquinate and Its Quinoline-
    Ramseier J; Imhof D; Anghel N; Hänggeli K; Beteck RM; Balmer V; Ortega-Mora LM; Sanchez-Sanchez R; Ferre I; Haynes RK; Hemphill A
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of Decoquinate Solid Dispersion by Hot-Melt Extrusion as an Oral Dosage Form Targeting Liver-Stage
    Wang H; Fan Y; Qin L; Cheng Z; Chen X; Zeng S; Liang S; Tong Y; Tao Z; Liu Y; Liu X; Ning X; Chen P; Zhao S; Chen X
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0221821. PubMed ID: 35658489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of protamine-hyaluronic acid coated core-shell nanoparticles for enhanced solubility, permeability, and oral bioavailability of decoquinate.
    Wei W; Lu M; Xu W; Polyakov NE; Dushkin AV; Su WK
    Int J Biol Macromol; 2022 Oct; 218():346-355. PubMed ID: 35878671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage
    Wong HN; Padín-Irizarry V; van der Watt ME; Reader J; Liebenberg W; Wiesner L; Smith P; Eribez K; Winzeler EA; Kyle DE; Birkholtz LM; Coertzen D; Haynes RK
    Front Chem; 2019; 7():901. PubMed ID: 31998692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro versus in Mice: Efficacy and Safety of Decoquinate and Quinoline-
    Ramseier J; Imhof D; Hänggeli KPA; Anghel N; Boubaker G; Beteck RM; Ortega-Mora LM; Haynes RK; Hemphill A
    Pathogens; 2023 Mar; 12(3):. PubMed ID: 36986369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and particle size reduction improve bioavailability of poorly water-soluble compounds with antimalarial activity.
    Wang H; Li Q; Reyes S; Zhang J; Xie L; Melendez V; Hickman M; Kozar MP
    Malar Res Treat; 2013; 2013():769234. PubMed ID: 23766925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
    Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytochemical screening, cytotoxicity assessment and evaluation of in vitro antiplasmodial and in vivo antimalarial activities of Mentha spicata L. methanolic leaf extract.
    Chatterjee A; Singh N; Chanu WK; Singh CB; Nagaraj VA
    J Ethnopharmacol; 2022 Nov; 298():115636. PubMed ID: 35998785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantum Chemical Lipophilicities of Antimalarial Drugs in Relation to Terminal Half-Life.
    Alia JD; Karl S; Kelly TD
    ACS Omega; 2020 Mar; 5(12):6500-6515. PubMed ID: 32258886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria.
    Wattanakul T; Baker M; Mohrle J; McWhinney B; Hoglund RM; McCarthy JS; Tarning J
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria.
    de Vries PJ; Dien TK
    Drugs; 1996 Dec; 52(6):818-36. PubMed ID: 8957153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.